Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S G Chrysant

Showing results (61-70 of 108) with videos related to

Pageof 11
Sort By:
Angiology|December 1, 1976
Effects of diuretics on lipid metabolism in patients with essential hypertensionS G Chrysant, G K Neller, B Dillard, et al.
Clinical Cardiology|September 1, 1985
Antihypertensive effectiveness of terazosin: a new long-acting alpha-adrenergic inhibitorS G Chrysant, I S Bal, B Johnson, et al.
Life Sciences|June 15, 1977
The effect of renal vasodilation and hypotonic volume expansion on water excretion in dogs after anesthesia and surgeryS G Chrysant, S M Townsend, R D Lindeman, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 26, 1999
Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studiesT Littlejohn, R Saini, K Kassler-Taub, et al.
Angiology|April 1, 1978
Hemodynamic changes induced by prolonged NaCl and DOCA administration in spontaneously hypertensive ratsS G Chrysant, G M Walsh, E D Frohlich, et al.
Chest|September 1, 1989
Treatment of severe hypertension with atenolol and betaxolol with once-daily regimens. Hemodynamic aspectsS G Chrysant, C Chrysant, I S Bal, et al.
Kidney International|January 1, 1979
Hemodynamic and metabolic evidence of salt sensitivity in spontaneously hypertensive ratsS G Chrysant, G M Walsh, D C Kem, et al.
Clinical Pharmacology and Therapeutics|June 1, 1983
Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalaprilS G Chrysant, R D Brown, D C Kem, et al.
The American Journal of Cardiology|June 1, 1978
Abrupt cessation of clonidine administration: a prospective studyT L Whitsett, S G Chrysant, B L Dillard, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2001
Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertensionS Oparil, D Williams, S G Chrysant, et al.
Pageof 11

Showing results (61-70 of 108) with videos related to

Sort By:
Pageof 11
Angiology|December 1, 1976
Effects of diuretics on lipid metabolism in patients with essential hypertensionS G Chrysant, G K Neller, B Dillard, et al.
Clinical Cardiology|September 1, 1985
Antihypertensive effectiveness of terazosin: a new long-acting alpha-adrenergic inhibitorS G Chrysant, I S Bal, B Johnson, et al.
Life Sciences|June 15, 1977
The effect of renal vasodilation and hypotonic volume expansion on water excretion in dogs after anesthesia and surgeryS G Chrysant, S M Townsend, R D Lindeman, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|November 26, 1999
Long-term safety and antihypertensive efficacy of irbesartan: pooled results of five open-label studiesT Littlejohn, R Saini, K Kassler-Taub, et al.
Angiology|April 1, 1978
Hemodynamic changes induced by prolonged NaCl and DOCA administration in spontaneously hypertensive ratsS G Chrysant, G M Walsh, E D Frohlich, et al.
Chest|September 1, 1989
Treatment of severe hypertension with atenolol and betaxolol with once-daily regimens. Hemodynamic aspectsS G Chrysant, C Chrysant, I S Bal, et al.
Kidney International|January 1, 1979
Hemodynamic and metabolic evidence of salt sensitivity in spontaneously hypertensive ratsS G Chrysant, G M Walsh, D C Kem, et al.
Clinical Pharmacology and Therapeutics|June 1, 1983
Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalaprilS G Chrysant, R D Brown, D C Kem, et al.
The American Journal of Cardiology|June 1, 1978
Abrupt cessation of clonidine administration: a prospective studyT L Whitsett, S G Chrysant, B L Dillard, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|October 6, 2001
Comparative efficacy of olmesartan, losartan, valsartan, and irbesartan in the control of essential hypertensionS Oparil, D Williams, S G Chrysant, et al.
Pageof 11